Redox Regulation of Intracellular Calcium Signaling
Project Number1R01DK103558-01A1
Contact PI/Project LeaderJOSEPH, SURESH K Other PIs
Awardee OrganizationTHOMAS JEFFERSON UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): An elevation of cytosolic free calcium concentration is an integral component of the mechanism by which cells respond to hormones, growth factors and neurotransmitters. D-myo-inositol 1,4,5-trisphosphate ( IP3 ) is an intracellular messenger mediating the mobilization of Ca2+ from intracellular stores by interaction with an ubiquitous receptor ( IP3R ) that acts as a ligand-gated Ca2+ channel. IP3Rs are redox sensitive channels and are sensitized by oxidative stress. However, the molecular basis of this regulation is poorly understood. Ca2+ released from IP3Rs is locally transmitted to the mitochondria and can stimulate metabolism, and in higher amounts, can also initiate cell death. The overarching hypothesis of this study is that redox modulation of IP3Rs is an important component of the regulation of Ca2+ signals in cell death pathways. The proposal encompasses the following three specific aims: 1] To measure and map redox changes in IP3Rs. We have developed methods to determine the redox state of IP3Rs in vivo which will be used to quantitate the effects of exogenous and endogenous agents causing oxidative stress. Preliminary studies using mass-spectroscopy identify a subset of 11 cysteines that become oxidized in IP3R-1. The type of oxidative modifications occurring will be identified. Redox-sensitive thiols will be mutate and the functional sensitivity to oxidative stress will be assessed. 2] To measure IP3R redox state at the ER/mitochondrial junction. We will test the hypothesis that the pool of IP3Rs located at the ER/mito junction is particularly prone to ROS modifications. We will employ subcellular fractionation and imaging methods utilizing targeted IP3Rs, ROS-sensitive fluorescent proteins, ROS-producing photosensitive probes and targeted catalases. 3] To investigate the role of IP3R redox changes in models of ER stress/apoptosis. We will test the hypothesis that ER-resident NADPH oxidases play an important role in IP3R redox regulation. Liver will be used as an experimental model to induce ER stress. The role of IP3R redox regulation in ER stress pathways activated by fructose will be examined. The long-term goal of the proposal is to obtain a detailed understanding of how oxidative stress impacts intracellular Ca2+ signaling under normal and disease conditions.
Public Health Relevance Statement
PUBLIC HEALTH RELEVANCE: Calcium signals produced by IP3 receptors are essential for the normal functioning of many tissues. Oxidative stress and defective IP3 receptor Ca2+ signaling are implicated in important diseases including diabetes, cancer cardiovascular and neurodegenerative diseases. Knowing how oxidative stress affects Ca2+ signaling will allow us to design new therapeutic strategies to modulate Ca2+ signals in disease states.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
053284659
UEI
R8JEVL4ULGB7
Project Start Date
01-April-2015
Project End Date
31-March-2019
Budget Start Date
01-April-2015
Budget End Date
31-March-2016
Project Funding Information for 2015
Total Funding
$350,438
Direct Costs
$225,000
Indirect Costs
$125,438
Year
Funding IC
FY Total Cost by IC
2015
National Institute of Diabetes and Digestive and Kidney Diseases
$350,438
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DK103558-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DK103558-01A1
Patents
No Patents information available for 1R01DK103558-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DK103558-01A1
Clinical Studies
No Clinical Studies information available for 1R01DK103558-01A1
News and More
Related News Releases
No news release information available for 1R01DK103558-01A1
History
No Historical information available for 1R01DK103558-01A1
Similar Projects
No Similar Projects information available for 1R01DK103558-01A1